Minerva Neurosciences, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the Annual Meeting of Stockholders held on June 1, 2017, in Boston, Massachusetts. The registrant, Minerva Neurosciences, Inc., is a Delaware corporation and an emerging growth company.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes
No material financial changes or operational updates are disclosed in this filing. The document serves to disclose the outcome of stockholder votes.
Management Commentary and Voting Results
Two proposals were submitted to a vote of security holders:
- Proposal 1: Election of Directors
- Three nominees were elected to serve until the 2020 annual meeting.
- Marc D. Beer: 27,002,323 For; 698,246 Withheld; 1,265,363 Broker Non-Votes.
- Dr. David Kupfer: 27,086,246 For; 614,323 Withheld; 1,265,363 Broker Non-Votes.
- Jan van Heek: 27,066,337 For; 634,232 Withheld; 1,265,363 Broker Non-Votes.
- Proposal 2: Ratification of Independent Auditor
- Deloitte & Touche LLP was ratified as the independent registered public accounting firm for the fiscal year ended December 31, 2017.
- Votes: 22,461,678 For; 6,502,761 Against; 1,493 Abstain.
Key Facts for Investor Verification
- Confirmation of the new Board of Directors composition for the term ending in 2020.
- Verification of the significant number of votes cast against the ratification of the independent auditor (6,502,761 against).
- Confirmation that the company maintains its status as an emerging growth company.